ACLY and cancer: Together these observations suggest that SIRT6 may coordinate histone deacetylation at its direct target genes with an inverse regulation of ACLY-dependent histone acetylation at acetyl-CoA responsive genes, providing a multi-pronged repression of distinct transcriptional programs that contribute to cancer cell malignant phenotypes.